17 nov
|
Alexion, AstraZeneca Rare Disease
|
Barcelona
17 nov
Alexion, AstraZeneca Rare Disease
Barcelona
Director to lead general value, access, and pricing strategies for Neurology, with a focus on NMOSD, in key EU markets. Shapes evidence generation and guides launch strategies in a hybrid Barcelona role.
📌 Global Nmosd Pricing & Access Lead (Barcelona)
🏢 Alexion, AstraZeneca Rare Disease
📍 Barcelona